Polydex Reports First Quarter Financial Results
13 juin 2008 11h50 HE
|
Polydex Pharmaceuticals Limited
TORONTO, June 13, 2008 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) has today reported financial results of operations for the first quarter of fiscal 2009, ending April 30,...
Polydex Pharmaceuticals Limited -- 2008 Fiscal Year End Results
30 avr. 2008 15h01 HE
|
Polydex Pharmaceuticals Limited
TORONTO, April 30, 2008 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) has announced the results for its fiscal year ended January 31, 2008. All figures are reported in U.S....
Polydex Announces Ushercell Prevents Systemic SHIV Infection in Rhesus Macaques in New Clinical Trial
26 févr. 2008 14h02 HE
|
Polydex Pharmaceuticals Limited
TORONTO, Feb. 26, 2008 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) reports that CONRAD, a lead investigator of Ushercell, has completed a clinical trial using rhesus monkeys....
Polydex Pharmaceuticals Receives Staff Deficiency Letter from Nasdaq
22 janv. 2008 16h56 HE
|
Polydex Pharmaceuticals Limited
TORONTO, Jan. 22, 2008 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) announced today that on January 18, 2008, it received a Nasdaq Staff Deficiency Letter from The Nasdaq Stock...
Polydex Pharmaceuticals Provides Third Quarter Report
14 déc. 2007 10h13 HE
|
Polydex Pharmaceuticals Limited
TORONTO, Dec. 14, 2007 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) reports financial results for its third fiscal quarter, the three-month period ended October 31, 2007.
...
Polydex Announces Commencement of Follow-up Study of Ushercell
03 déc. 2007 09h53 HE
|
Polydex Pharmaceuticals Limited
TORONTO, Dec. 3, 2007 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) reports that CONRAD, a lead investigator of Ushercell, has commenced a Phase I trial to assess the safety of...
Polydex Moving Forward With Contraceptive Development and Building for the Future
01 oct. 2007 09h30 HE
|
Polydex Pharmaceuticals Limited
TORONTO, Oct. 1, 2007 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) today issued the following report on Company operations and objectives for the future.
Cash and cash...
Final Report of Ushercell as Treatment for Bacterial Vaginosis Released
17 sept. 2007 08h00 HE
|
Polydex Pharmaceuticals Limited
TORONTO, Sept. 17, 2007 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) announces that a final report has been received from Dr. Jose Simoes, the Principal Investigator in a Phase...
Polydex Reports Second Quarter Financial Results
14 sept. 2007 11h00 HE
|
Polydex Pharmaceuticals Limited
TORONTO, Sept. 14, 2007 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) reports on financial results of operations for the second quarter of fiscal 2008, ending July 31, 2007.
...
Analysis of Ushercell HIV Trials Reveals Difference in Seroconversion Groups Not Statistically Significant
25 juil. 2007 07h00 HE
|
Polydex Pharmaceuticals Limited
TORONTO, July 25, 2007 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) reports that today at the International AIDS Society 2007 Conference in Sydney Australia, Dr. Lut Van Damme of...